Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Beijing Wandong Medical Technology Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥14.74 |
52 Week High | CN¥26.10 |
52 Week Low | CN¥11.23 |
Beta | -0.088 |
1 Month Change | -2.32% |
3 Month Change | -13.70% |
1 Year Change | -39.27% |
3 Year Change | 12.61% |
5 Year Change | 4.39% |
Change since IPO | 692.61% |
Recent News & Updates
Shareholder Returns
600055 | CN Medical Equipment | CN Market | |
---|---|---|---|
7D | -7.3% | -5.9% | -4.9% |
1Y | -39.3% | -18.0% | -16.6% |
Return vs Industry: 600055 underperformed the CN Medical Equipment industry which returned -18% over the past year.
Return vs Market: 600055 underperformed the CN Market which returned -16.6% over the past year.
Price Volatility
600055 volatility | |
---|---|
600055 Average Weekly Movement | 7.1% |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 8.2% |
10% most volatile stocks in CN Market | 11.5% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 600055 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600055's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1955 | 1,059 | Yu Feng Xie | https://www.wandong.com.cn |
Beijing Wandong Medical Technology Co.,Ltd. engages in the research and development, manufacturing, and sale of medical diagnostic service. It offers MRI solutions; radiological imaging solutions, including CT system, CGO series, DR system, DRF system, digital mammography, and mobile X-ray equipment.
Beijing Wandong Medical Technology Co.,Ltd. Fundamentals Summary
600055 fundamental statistics | |
---|---|
Market cap | CN¥10.36b |
Earnings (TTM) | CN¥188.54m |
Revenue (TTM) | CN¥1.24b |
55.0x
P/E Ratio8.4x
P/S RatioIs 600055 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600055 income statement (TTM) | |
---|---|
Revenue | CN¥1.24b |
Cost of Revenue | CN¥715.71m |
Gross Profit | CN¥520.96m |
Other Expenses | CN¥332.42m |
Earnings | CN¥188.54m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.27 |
Gross Margin | 42.13% |
Net Profit Margin | 15.25% |
Debt/Equity Ratio | 0.02% |
How did 600055 perform over the long term?
See historical performance and comparison